ATE343595T1 - Peptide enthaltend eine cholesterin- erkennungssequenz und deren verwendungen - Google Patents

Peptide enthaltend eine cholesterin- erkennungssequenz und deren verwendungen

Info

Publication number
ATE343595T1
ATE343595T1 AT99912635T AT99912635T ATE343595T1 AT E343595 T1 ATE343595 T1 AT E343595T1 AT 99912635 T AT99912635 T AT 99912635T AT 99912635 T AT99912635 T AT 99912635T AT E343595 T1 ATE343595 T1 AT E343595T1
Authority
AT
Austria
Prior art keywords
peptides containing
detection sequence
cholesterol detection
cholesterol
sequence
Prior art date
Application number
AT99912635T
Other languages
English (en)
Inventor
Vassilios Papadopoulos
Hua Li
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Application granted granted Critical
Publication of ATE343595T1 publication Critical patent/ATE343595T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99912635T 1998-03-12 1999-03-12 Peptide enthaltend eine cholesterin- erkennungssequenz und deren verwendungen ATE343595T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7775398P 1998-03-12 1998-03-12

Publications (1)

Publication Number Publication Date
ATE343595T1 true ATE343595T1 (de) 2006-11-15

Family

ID=22139865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912635T ATE343595T1 (de) 1998-03-12 1999-03-12 Peptide enthaltend eine cholesterin- erkennungssequenz und deren verwendungen

Country Status (8)

Country Link
EP (1) EP1129112B1 (de)
JP (1) JP2003521223A (de)
AT (1) ATE343595T1 (de)
AU (2) AU776298B2 (de)
CA (1) CA2327329A1 (de)
DE (1) DE69933785T2 (de)
ES (1) ES2274621T3 (de)
WO (1) WO1999046575A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05007322A (es) 2003-01-06 2006-02-17 Angiochem Inc Aprotinina y analogos como portadores a traves de la barrera sangre-cerebro.
WO2007136819A2 (en) * 2006-05-19 2007-11-29 Georgetown University Use of peptides containing a cholesterol interaction sequence for treating hypercholesterolemia, viral infection, obesity and diabetes
CA2666841A1 (en) 2006-10-19 2008-04-24 Angiochem, Inc. Compounds for stimulating p-glycoprotein function and uses thereof
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
BRPI0920209A2 (pt) 2008-10-15 2015-12-22 Angiochem Inc conjugados de agonistas de glp-1 e usos dos mesmos
JP6823055B2 (ja) 2015-06-15 2021-01-27 アンジオケム インコーポレーテッド 軟髄膜癌腫症の治療方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
WO1999046389A1 (en) * 1998-03-11 1999-09-16 Immunomedics, Inc. Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase

Also Published As

Publication number Publication date
AU2004235618A1 (en) 2005-01-06
AU2004235618B2 (en) 2007-10-11
EP1129112A2 (de) 2001-09-05
CA2327329A1 (en) 1999-09-16
AU3096899A (en) 1999-09-27
DE69933785T2 (de) 2007-10-04
AU776298B2 (en) 2004-09-02
WO1999046575A2 (en) 1999-09-16
JP2003521223A (ja) 2003-07-15
DE69933785D1 (de) 2006-12-07
WO1999046575A3 (en) 2001-06-28
EP1129112B1 (de) 2006-10-25
ES2274621T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
DE69832158D1 (de) Isolierung und strukturelle aufklärung der kryostatischen linearen und cyclo-depsipeptide dolastatin 16, dolastatin 17, und dolastatin 18
DE69515371D1 (de) Suche und Vergleich von nicht-erkannter Handschrift
DE69414471T2 (de) Dichtungsanordnung zur Einführung von chirurgischen Instrumenten
BR9607582A (pt) Composto e peptídeo ou substância peptidomimética
DE69522301T2 (de) Dichtungsanordnung zur Einführung von chirurgischen Instrumenten
DE69623569T2 (de) System zur Zeichenerkennung und Übersetzung
AU2072002A (en) Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
DE69731357D1 (de) Funktionelles antigenfragment von tetanustoxin und tetanusvakzine
NO995928D0 (no) <alfa>-1-antitrypsin-preparater samt fremgangsmåte ved fremstilling derav
ATE343595T1 (de) Peptide enthaltend eine cholesterin- erkennungssequenz und deren verwendungen
DE59812513D1 (de) Verwendung von W/O-Emulsionen als Verdicker in kosmetischen und pharmazeutischen Zubereitungen
IT1283953B1 (it) Ciocca di capelli per l'allungamento e l'ispessimento o infoltimento dei capelli umani.
DE69221849D1 (de) Serum und Plasma trennende Mischungen und Bluttest-Behälter
EP0989136A4 (de) Peptide mit zyklischen strukturen, die die aktivität von mutierten p53 proteinen wiederherstellen können.
ATE283706T1 (de) ßGEGEN RACEMISIERUNG STABILISIERTE PHARMAZEUTISCHE ZUBEREITUNGEN VON CILANSETRONß
EP1702985A3 (de) Bevorzugte neurofilamentprotein Segmente und Methode zu ihrer Verwendung
NO20002001L (no) Peptider i stand til Õ inhibere interaksjonen mellom preseniliner og <beta>-amyloidpeptidet eller dettes forløper
DE69816241D1 (de) Aktivierte peptide und konjugate
GB0122200D0 (en) Concentration of protein and/or peptide samples
GB2305242A (en) Detection of sulphur containing compounds
FR2784297B1 (fr) Appareil d'assistance respiratoire comportant plusieurs sources de gaz respiratoire agencees en serie
FR2723314B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant un extrait de centaurium erythraea et un extrait de siegesbeckia orientalis
EE9800108A (et) Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid
TR199701658T1 (xx) Oto-ba����kl�k hastal�klar�nda T-h�cresi arac�l���yla ortaya ��kan k�k�rdak tahriplerinin tedavisinde kullan�lmak i�in yeni peptidler.
ATE224761T1 (de) Zikoniumoxid enthaltende vorrichtung zur plasmagestützten gasbehandlung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1129112

Country of ref document: EP

REN Ceased due to non-payment of the annual fee